
Read More
127% Return in 1 Year: This Multibagger Pharma Company Approves Rs 100 Cror...
Senores Pharmaceuticals has approved a proposal to reallocate Rs 100.02 crore of its unutilised IPO ...

Senores Pharmaceuticals has approved a proposal to reallocate Rs 100.02 crore of its unutilised IPO ...

Senores Pharmaceuticals reported Q4FY26 total income of Rs 190 crore and PAT of Rs 37 crore, while r...

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 285 per c...